King C H, Shlaes D M, Dul M J
J Clin Microbiol. 1983 Jul;18(1):79-83. doi: 10.1128/jcm.18.1.79-83.1983.
We first noted the appearance of thymidine-requiring, gram-negative bacilli in clinical specimens 2 years ago. Since then we have seen 10 patients colonized or infected with these organisms. These strains do not grow on Mueller-Hinton media, growth on MacConkey agar is variable, and growth in API 20E (Analytab Products) and Enterobacteriaceae-Plus Cards (AutoMicrobic system; Vitek Systems Inc.) is inadequate for reliable identifications. Thymidine-requiring organisms are routinely resistant to sulfonamides and trimethoprim. Infection or colonization is associated with previous sulfamethoxazole-trimethoprim therapy in most cases. Of 10 patients, 1 had septicemia of urinary tract origin, 5 had urinary tract colonization or infection, 2 had wound colonization, and two had colonization of respiratory secretions. Thymidine-requiring, gram-negative bacilli can be pathogens and present potential problems in diagnosis, identification, and susceptibility testing.
两年前我们首次在临床标本中注意到需要胸苷的革兰氏阴性杆菌。从那时起,我们已经发现10例患者被这些微生物定植或感染。这些菌株在穆勒-欣顿培养基上不生长,在麦康凯琼脂上的生长情况不一,在API 20E(Analytab Products公司)和肠杆菌科加卡片(自动微生物系统;Vitek系统公司)中生长不足以进行可靠鉴定。需要胸苷的微生物通常对磺胺类药物和甲氧苄啶耐药。在大多数情况下,感染或定植与先前的磺胺甲恶唑-甲氧苄啶治疗有关。10例患者中,1例有尿路感染引起的败血症,5例有尿道定植或感染,2例有伤口定植,2例有呼吸道分泌物定植。需要胸苷的革兰氏阴性杆菌可能是病原体,在诊断、鉴定和药敏试验中存在潜在问题。